JP2024504467A5 - - Google Patents
Info
- Publication number
- JP2024504467A5 JP2024504467A5 JP2023545955A JP2023545955A JP2024504467A5 JP 2024504467 A5 JP2024504467 A5 JP 2024504467A5 JP 2023545955 A JP2023545955 A JP 2023545955A JP 2023545955 A JP2023545955 A JP 2023545955A JP 2024504467 A5 JP2024504467 A5 JP 2024504467A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- polypeptide
- nucleic acid
- acid residue
- represents amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21154636.1 | 2021-02-01 | ||
| EP21154636 | 2021-02-01 | ||
| PCT/EP2022/052282 WO2022162233A2 (en) | 2021-02-01 | 2022-02-01 | Polypeptide inhibitors of lactate dehydrogenase activity for use in cancer therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024504467A JP2024504467A (ja) | 2024-01-31 |
| JP2024504467A5 true JP2024504467A5 (https=) | 2025-02-13 |
Family
ID=74494850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023545955A Pending JP2024504467A (ja) | 2021-02-01 | 2022-02-01 | がん療法で使用するための乳酸脱水素酵素活性のポリペプチド阻害剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240116987A1 (https=) |
| EP (1) | EP4284920A2 (https=) |
| JP (1) | JP2024504467A (https=) |
| AU (1) | AU2022214391A1 (https=) |
| CA (1) | CA3206455A1 (https=) |
| WO (1) | WO2022162233A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3138822A1 (en) * | 2019-05-02 | 2020-11-05 | Universite Catholique De Louvain | Lactate dehydrogenase inhibitor polypeptides for use in the treatment of cancer |
| US12357256B2 (en) * | 2023-06-23 | 2025-07-15 | Smart Breast Corporation | Computer assisted molecular imaging methods and systems |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4675187A (en) | 1983-05-16 | 1987-06-23 | Bristol-Myers Company | BBM-1675, a new antibiotic complex |
| AU3395900A (en) * | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
| US6444425B1 (en) * | 1999-04-02 | 2002-09-03 | Corixa Corporation | Compounds for therapy and diagnosis of lung cancer and methods for their use |
| US20050130263A1 (en) * | 1999-10-29 | 2005-06-16 | Genesis Research And Development Corp. Ltd. | Compositions isolated from bovine mammary gland and methods for their use |
| RU2556800C2 (ru) | 2010-06-14 | 2015-07-20 | Ф.Хоффманн-Ля Рош Аг | Пептиды, проникающие в клетки, и их применения |
| CA3138822A1 (en) * | 2019-05-02 | 2020-11-05 | Universite Catholique De Louvain | Lactate dehydrogenase inhibitor polypeptides for use in the treatment of cancer |
-
2022
- 2022-02-01 AU AU2022214391A patent/AU2022214391A1/en active Pending
- 2022-02-01 WO PCT/EP2022/052282 patent/WO2022162233A2/en not_active Ceased
- 2022-02-01 EP EP22701267.1A patent/EP4284920A2/en active Pending
- 2022-02-01 US US18/263,756 patent/US20240116987A1/en active Pending
- 2022-02-01 JP JP2023545955A patent/JP2024504467A/ja active Pending
- 2022-02-01 CA CA3206455A patent/CA3206455A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024504467A5 (https=) | ||
| JP2024178382A5 (https=) | ||
| JP2021534798A5 (https=) | ||
| JPWO2019156137A5 (https=) | ||
| JP2020023567A5 (https=) | ||
| JP2004511201A5 (https=) | ||
| JP2010536714A5 (https=) | ||
| JP2008536483A5 (https=) | ||
| TW200904419A (en) | Modulators of pharmacokinetic properties of therapeutics | |
| JP2024533312A5 (https=) | ||
| JPWO2019107530A5 (https=) | ||
| EA019965B1 (ru) | Комбинация ингибитора протеазы ns3 hcv с интерфероном и рибавирином | |
| JP2021518159A5 (https=) | ||
| JP2023538422A5 (https=) | ||
| AU2007275860A1 (en) | Modulators of pharmacokinetic properties of therapeutics | |
| JP2016538885A5 (https=) | ||
| JP2020530282A5 (https=) | ||
| JP2018515101A5 (https=) | ||
| JP2019534884A5 (https=) | ||
| JP2024533315A5 (https=) | ||
| JP2006506097A5 (https=) | ||
| JP2024511131A5 (https=) | ||
| JP2022506716A5 (https=) | ||
| TW201138773A (en) | Dosage regimens for HCV combination therapy | |
| JP2024542995A5 (https=) |